Auricular Neuromodulation for FESS
NCT: NCT06662422 · COMPLETED
Brief Summary
In this blinded prospective randomized control trial the researchers will investigate the impact of cutaneous vagal nerve stimulation on surgical conditions in patients undergoing functional and ascorbic sinus surgery (FESS). The device is an externally placed vagal nerve stimulator. The device will be applied to participants after consent and induction of anesthesia. The study team will open the randomization envelope and if the participant is assigned to stimulation the device will be turned on. In the case that the participant is assigned to the control arm, the device will be set to sham. The device will remain on for 30 minutes and removed before entering the OR. Device will be reinserted in the recovery room for another 30 minutes.
Frequently Asked Questions
What is Auricular Neuromodulation for FESS?
Auricular Neuromodulation for FESS is a clinical trial registered under NCT06662422. Current status: COMPLETED.
What is the status of NCT06662422?
The current status of NCT06662422 (Auricular Neuromodulation for FESS) is: COMPLETED.
When did Auricular Neuromodulation for FESS start?
Auricular Neuromodulation for FESS started on 2024-10-23.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.